 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Overview Details

What is this course about?

Who is this mini-course for?

Teaching goals (learning objectives)

Slide-by-Slide Presentation

Slide 1 — Opening Hook

Slide 2 — Concept Simplified

Slide 3 — Case Study with Characters and Dialogue

Slide 4 — Practical Application

Slide 5 — Knowledge Check + Takeaways

10-Point Audit / Inspection-Readiness Checklist

Knowledge Check — 5 Multiple-Choice Questions

Q1. An analyst injects one prepared sample solution six times and reports the %RSD of the six peak areas as the method's repeatability. What is the primary problem?

Q2. Which of these satisfies the Q2(R2) design options for a repeatability study?

Q3. A repeatability result is 2.4% against a protocol criterion of ≤2.0%. One of six values looks high and the analyst suspects a preparation error but has no documented assignable cause. The transfer deadline is tomorrow. What is the compliant action?

Q4. Under ICH Q2(R2), where does the "%RSD ≤ 2.0%" acceptance limit for an assay come from?

Q5. Which set of conditions correctly defines a repeatability study versus the next level of precision?

Course Evaluation and Feedback

Training Effectiveness and Content Relevance Survey

Learner Confidence and Knowledge Application Survey

Welcome to the definitive guide on "Evaluating Repeatability and Intra-Assay Precision per ICH Q2(R2). " In the highly regulated pharmaceutical and biopharmaceutical industries, ensuring the reliability of analytical procedures is paramount to patient safety and continuous product quality.

Welcome to the definitive guide on "Evaluating Repeatability and Intra-Assay Precision per ICH Q2(R2)." In the highly regulated pharmaceutical and biopharmaceutical industries, ensuring the reliability of analytical procedures is paramount to patient safety and continuous product quality. This comprehensive mini-course is designed to demystify the foundational rationale for repeatability and its critical role in isolating the irreducible noise of an analytical procedure under the same operating conditions.

Are you struggling to differentiate repeatability from intermediate precision and reproducibility? Do you want to understand the overarching objectives of evaluating precision per ICH Q2(R2) Section 3.1.3.1? This course provides a deep dive into the strict conditions that constitute a repeatability study, including experimental design options and required statistical outputs like standard deviation (SD) and relative standard deviation (%RSD/CV).

Through engaging slide-by-slide presentations, realistic case studies, and practical applications, you will learn how to implement the correct end-to-end workflow for a repeatability study. We will explore how uncharacterized method noise can falsely manifest as product variation and the real-world consequences of poor intra-assay precision on routine QC operations. By the end of this course, you will be equipped with a 10-Point Audit/Inspection-Readiness Checklist to ensure your precision study documentation is contemporaneous, transparent, and defensible against regulatory scrutiny. Join us to bridge your knowledge gaps, reduce OOS/OOT investigations, and ensure robust batch release processes.

Evaluating Repeatability and Intra-Assay Precision per ICH Q2(R2)

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>Analytical procedure validation serves as the cornerstone of pharmaceutical quality control, ensuring that testing methods consistently yield reliable data for batch disposition and stability monitoring. Within the updated framework of ICH Q2(R2), evaluating repeatability—often referred to as intra-assay precision—is a critical requirement for isolating the irreducible noise inherent to an analytical procedure when executed under identical operating conditions. Uncharacterized or excessive method variability can easily masquerade as product variation, leading to unwarranted Out of Specification (OOS) or Out of Trend (OOT) investigations that disrupt supply chains. By rigorously establishing repeatability using the same analyst, identical equipment, and a short time interval, laboratories can confidently differentiate true manufacturing deviations from analytical artifacts, thereby safeguarding patient safety and ensuring robust product quality assurance.</p>

<p>This comprehensive program is structured to guide quality control analysts, validation specialists, and quality assurance reviewers through the end-to-end workflow of a compliant repeatability study. The curriculum systematically addresses the foundational rationale of intra-assay precision, clearly differentiating it from intermediate precision and reproducibility within the ICH Q2(R2) hierarchy. Participants will examine acceptable experimental design options, such as executing a minimum of nine determinations across the specified range or six independent determinations at the 100% test concentration, alongside the required statistical treatments including standard deviation and relative standard deviation (%RSD). Through practical case studies, slide-by-slide analyses, and a rigorous 10-point inspection-readiness checklist, professionals will acquire the competencies necessary to design scientifically justified protocols, appropriately handle marginal data without resorting to non-compliant outlier removal, and confidently defend validation packages against stringent regulatory scrutiny.</p>
        </div>
    </div>
</div>
